eric
10-31-2006, 07:26 PM
http://www.tickertech.com/cgi/?a=news&ticker=a&w=&story=200610200610310830PR_NEWS_USPR_____SFTU082
Bionovo's Phase 1/2 Clinical Trial Protocol for Metastatic Breast Cancer Accepted by FDA
Novel Pro-Apoptotic Agent Shown to Kill Cancer Cells While Leaving Normal Cells Intact
Bionovo's Phase 1/2 Clinical Trial Protocol for Metastatic Breast Cancer Accepted by FDA
Novel Pro-Apoptotic Agent Shown to Kill Cancer Cells While Leaving Normal Cells Intact